In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.
Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries Kuros will work collaboratively to ...
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to sel ...
MagnetOs is not cleared by the FDA or TGA as an osteoinductive bone graft. ‡ MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ...
underscoring a shared commitment to expanding access to Kuros' pioneering MagnetOs bone grafting technology. This agreement positions Kuros for new opportunities in the U.S. spine market and also ...
Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback